background preloader

Medsafe.gov.nz

Medsafe.gov.nz
Related:  Pharmaceutical Medicine - Regulatory Affairs 2

Everybody - Health Information for New Zealanders 21st Century Cures - FasterCures The 21st Century Cures Act (P.L. 114-255) is landmark, bipartisan legislation that was signed into law on Dec. 13, 2016, and touches virtually all aspects of biomedical research, medical product development and the regulatory approval process. Read what FasterCures has said about 21st Century Cures over the years. FasterCures worked closely with Congress, federal agencies and the advocacy community throughout the legislation’s journey to the president’s desk. In February 2017, we debuted the 21st Century Cures Tracker to track the implementation of the 100+ sections in Division A, which include the key provisions relevant to biomedical research and innovation. (Other divisions of the law pertain to mental health and Medicare; since those are not areas of focus for FasterCures, we will not be actively tracking them here.) Learn more about how to use the tracker with our FAQs page. Please keep coming back, as we will be updating the information regularly. Send us your feedback and updates

Ministry for Culture and Heritage PubMed Tutorial - Overview Introduction Welcome to the PubMed Tutorial. This course is designed for new and experienced users of PubMed®, the National Library of Medicine (NLM®) journal literature search system. Goals and Objectives By the end of this course, you should be able to: Understand PubMed's scope and content. For brief tutorials on specific topics, see also the PubMed Quick Tours This tutorial was updated in February 2014, and reflects PubMed changes through December, 2013. See system requirements. Learn how to move around the modules of the PubMed Tutorial or jump right into learning about PubMed. Next Section >

Regulatory intelligence Recently I came across a perfect and involuntary example of business blindness in a financial magazine, which led me to ponder on the real meaning of intelligence, from a professional perspective. The whole winter issue of the publication was dedicated to emerging markets, but one sentence caught my attention: 'Libya is not only a place where political and economical stability lie, but one of the major opportunities to invest your money…' The word 'intelligence' is biased, since in most European languages it means 'the intellect, the understanding (of a person or an animal)'. However, the English language includes a further subtle definition, according to the Oxford English Dictionary: 'the collection of information, especially of military or political value.' Being a regulatory professional in the pharmaceutical field, I started thinking about 'regulatory intelligence' (RI), its definition, implications and value. In recent years, RI has evolved rapidly and is now a speciality. 1.

NOAH - New York Online Access to Health Home The National Library of Medicine's Visible Human Project Overview The Visible Human Project® is an outgrowth of the NLM's 1986 Long-Range Plan. It is the creation of complete, anatomically detailed, three-dimensional representations of the normal male and female human bodies. Acquisition of transverse CT, MR and cryosection images of representative male and female cadavers has been completed. The long-term goal of the Visible Human Project® is to produce a system of knowledge structures that will transparently link visual knowledge forms to symbolic knowledge formats such as the names of body parts. The National Library of Medicine thanks the men and the women who will their body to science, thereby enabling medical research and development. Further Information

Legalities Surrounding Pharmaceutical Industry In UAE - Food, Drugs, Healthcare, Life Sciences - United Arab Emirates Registration Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes: To allow you to personalize the Mondaq websites you are visiting.To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.To produce demographic feedback for our information providers who provide information free for your use. Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services. If you do not want us to provide your name and email address you may opt out by clicking here Terms & Conditions and Privacy Statement Use of www.mondaq.com Disclaimer

BMJ BestTreatments Home Best Health gives you reliable, easy-to-understand information, to help you make the best decisions about your healthcare. Discover all you need to know about medical conditions, and find out which treatments really work. Best Health sets out your treatment options, and rates them according to their benefits and side effects. All our information comes from high-quality research, from the same sources your doctors rely on. You can also try Best Health for free.

New Regulation on Criteria and Drug Registration Procedure General On 24th November 2017, Food and Drugs Supervisory Agency (Badan Pengawas Obat dan Makanan - "BPOM") Regulation No. 24 of 2017 on Criteria and Drug Registration Procedure ("Regulation 24") was enacted. The government had viewed that the previous regulation had to be adapted to keep up with the latest developments in science and technology. This new regulation revokes Head of the National Agency for Food and Drugs Control Regulation Numbers HK.03.1.23.10.11.08481-2011, 3/2013 and 17/2016 on the same matter. Implication for Applicants BPOM intends to cover the registration of more types of drug products in Indonesia with the issuance of Regulation 24. Key Changes The following are key changes under Regulation 24. Definition of and registration of Generic Drugs (Obat Generik), Branded Generic Drugs (Obat Generik Bermerek) and First Generic Drugs (Obat Generik Pertama) Exemption from Product Registration Requirement Criteria of Drugs Category of Registration Registration of Imported Drugs

NSW State Library - drug info @ your library Papua New Guinea: Medicines and Cosmetics Act 1999 Medicines and Cosmetics Act 1999 No. 10 of 1999. Medicines and Cosmetics Act 1999 . Certified on: / /20 . 1. Compliance with constitutional requirements. 2. entitled Medicines and Cosmetics Act 1999, Being an Act– (a) to make provisions with respect to medicinal products and medical advertisements and matters connected therewith; and (b) to repeal the Pharmacy Act (Chapter 94) and the Therapeutic Goods and Cosmetics Act 1984; and (c) to make consequential amendments to the Poisons and Dangerous Substances Act 1952, and for related purposes. (1) This Act, to the extent that it regulates or restricts the rights or freedoms conferred by Division III.3.C. (a) the right to freedom from arbitrary search and entry conferred by Section 44 of the Constitution; and (b) the right to freedom of expression conferred by Section 46 of the Constitution; and (c) the right to privacy conferred by Section 49 of the Constitution; and (d) the right to freedom of movement conferred by Section 52 of the Constitution,

Related: